Amplifold
PrivateLast Round
Seed
Dec 10, 2025
Total Funding Raised
$5.82M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Amplifold operates in Healthcare & Life Sciences and is based in Germany. Its latest recorded funding round was a Seed round in December 2025.
Amplifold is a biotechnology company that develops a DNA-origami-based signal amplification platform to enhance the sensitivity of lateral flow assays.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amplifold Comparables
Compare Amplifold with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Detechgene | 75% | |
| Torus Biosystems | 73% | |
| Danaher | 72% |
For institutional investors. Book with your work email.
Amplifold Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Amplifold Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| xista science ventures | Seed |
| Becker Ventures | Seed |
| xista science ventures | Seed |
| Matterwave Ventures | Seed |
| b2venture | Seed |
| Becker Ventures | Seed |
| Bayern Kapital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
Dr Federico Bürsgens to join as CEO, effective July 1st, 2026.
- May 15, 2026
Monthly visitors increased 215% MoM.
For institutional investors. Book with your work email.
Amplifold Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Amplifold's valuation, stock price, and market status.
Is Amplifold a public or private company?
Amplifold is a private company.
What is the current stock price of Amplifold?
Amplifold is a private company, so its shares have no public market price. Caplight tracks Amplifold's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Amplifold worth (valuation)?
Valuation information for Amplifold is not publicly available.
Can I buy Amplifold stock?
Amplifold shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Amplifold's last funding round?
Amplifold's most recent funding round was Seed on December 10, 2025.
Who are the main investors in Amplifold?
Key investors in Amplifold include xista science ventures, xista science ventures, Matterwave Ventures.
Will Amplifold IPO soon?
No public IPO plans have been announced for Amplifold.
How can I track Amplifold secondary market activity?
Caplight tracks bids, offers, and trades in Amplifold's shares on secondary markets.